FDA Clears Siemens’ New 3T MRI
Siemens Healthcare announced FDA approval of their MAGNETOM Prisma, a 3T MRI scanner.
Siemens Healthcare announced FDA approval of their MAGNETOM Prisma, a 3T MRI scanner designed to provide high spatial and temporal resolution, particularly in highly demanding applications.
The MAGNETOM Prisma features XR Gradients, which combine 80 milliTesla per meter with a 200T-per-meter-per-second slew rate to offer a configuration unavailable in any other commercial whole-body system. The system is designed to maintain precision throughout long, demanding applications such as functional MRI. The system’s first-to-market Diffusion Spectrum Imaging (DSI) acquisition enables the user to potentially resolve fine anatomical details of the brain such as crossing white-matter fibers, the company said.
MAGNETOM Prisma’s benchmark homogeneity and advanced shimming solutions allow for finer, more effective compensation of patient-induced field disturbances. The MAGNETOM Prisma has Siemens’ Dot (Day optimizing throughput) engines that enable consistency for research applications and clinical work, the company said. The Dot engine brings automation and reproducibility to investigations across subjects, time points, and institutions.
Siemens will offer onsite upgrades to the MAGNETOM Prisma to customers who have already installed the MAGNETOM Trio.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
